Download presentation

Presentation is loading. Please wait.

Published byBrent Crowhurst Modified over 2 years ago

1
Counts TLR3-PE 100 80 60 40 20 0 Counts TLR8-PE 100 80 60 40 20 0 Counts TLR9-PE 100 80 60 40 20 0 C AB Supplemental Figure 1

2
A 250 200 150 100 50 0 TLR7-PE No. of living cells (in million) B 1.5 1 0.5 0 PBS CL264 Cisplatin CL264+ Cisplatin Percentage (apoptotic cells) 50 40 30 20 10 0 PBS CL264 Cisplatin CL264+ Cisplatin Counts ** *** Supplemental Figure 2

3
6000 4000 2000 0 14000 12000 10000 8000 PBS CL264 Cisplatin(100µM)Cisplatin(200µM) Cisplatin(300µM) CL264+Cisplatin(100µM)CL264+Cisplatin(200µM) CL264+Cisplatin(300µM) ns Tumor volume (mm 3 ) ** Supplemental Figure 3

4
A B Tumor volume (mm 3 ) day 28 7500 6000 4500 3000 1500 0 CL264 Cisplatin IRS661 ODN -+-++-+ --++-++ ----+++ ++++--- - - + - Supplemental Figure 4

5
10 20 40 30 0 PBS CL264 %CD3+ cells among CD45+ cells ns PBS CL264 0 5 10 15 20 nb CD3+ cells (x10 6 ) ns PBS CL264 %CD3+ CD4+ cells among CD45+ cells 80 60 100 40 20 0 ns PBS CL264 nb CD3+ CD4+ cells (x10 6 ) 0 5 10 15 ns CD3 + T cellsCD4 + T cells PBS CL264 2 4 8 6 0 10 %CD3+ CD8+ cells among CD45+ cells ns PBS CL264 nb CD3+ CD8+ cells (x10 6 ) 0 1 2 3 ns CD8 + T cells PBS CL264 0 2 4 6 8 %CD3+ Foxp3+ cells among CD45+ cells ns nb CD3+ Foxp3+ cells (x10 6 ) PBS CL264 0 1 2 3 ns CD3 + Foxp3 + T Reg cells PBS CL264 0 5 10 15 20 %Gr1- CD11c+ cells among CD45+ cells nb Gr1- CD11c+ cells (x10 6 ) 0 5 10 15 PBS CL264 Gr1 - CD11c + dendritic cells PBS CL264 %Gr1- CD11b+ cells among CD45+ cells 0 20 40 60 PBS CL264 0 0.5 1 1.5 nb Gr1- CD11b+ cells (x10 6 ) Gr1 - CD11b + macrophages PBS CL264 10 20 40 30 %Gr1+ CD11b+ cells among CD45+ cells 0 PBS CL264 0.5 1 1.5 0 nb Gr1+ CD11b+ cells (x10 6 ) Gr1 + CD11b + MDSCs A B CD EF G ** Supplemental Figure 5

6
P value Percentage of TLR7 expressing tumor cells Supplemental Figure 6

7
P value Percentage of TLR7 expressing tumor cells Supplemental Figure 7

8
Overall Survival (OS) Time (months) 1.6.8.4 0.2 0 20 40 60 80 100 120 Responders =55/166 Non-responders =111/166 P = 0.00218 Supplemental Figure 8

9
R 2 = 0.5084 p= 0.0009 % TLR7 in tumor cells in LN after chemotherapy % TLR7 in tumor cells in lung after chemotherapy 100 80 60 40 20 0 40 6080100 0 Supplemental Figure 9

10
No Yes % TLR7 positive tumoral cells Tumor Downstaging A 100 80 60 40 20 0 B Yes 100 80 60 40 20 0 No Lymph Node Downstaging % TLR7 positive tumoral cells PatientsMean %TLR7 expressing cells P value for the mean Median %TLR7 expressing cells P value for the median Tumor downstaging Yes27 0.0053 0 0.0013 No4750 Lymph Node downstaging Yes28 0.0002 2 0.0003 No51 50 C Supplemental Figure 10

Similar presentations

Presentation is loading. Please wait....

OK

Shimura Supplemental Figure 1

Shimura Supplemental Figure 1

© 2017 SlidePlayer.com Inc.

All rights reserved.

Ads by Google

Ppt on latest technology in electronics and instrumentation Ppt on motion force and pressure for class 9 Ppt on world environment day 2011 Ppt on solar power system Ppt on online library management system Ppt on tools of data collection Ppt on historical places in pune Ppt on the solar system Ppt on object oriented programming language Ppt on credit policy variables